Biotech Business Week articles from December 2004

Biotech Business Week archives from December 2004

Two-year follow-up data released from Enteryx procedure clinical trial.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced 2-year follow-up data from its ongoing Enteryx procedure clinical trial for the treatment of gastroesophageal reflux disease (GERD) symptoms. David...

Positive trial results reported on cardiac support device.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Acorn Cardiovascular announced that data presented at the Late Breaking Clinical Trials Session of the American Heart Association (AHA) 2004 Scientific Sessions indicates that the company's CorCap...

FDA grants approval for new formulation of TriCor.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Abbott (ABT) announced that it received U.S. Food and Drug Administration approval to market a new formulation of TriCor (fenofibrate) Tablets for the treatment of lipid disorders such as mixed...

U.S FDA grants orphan drug designation for CR002 in IgA nephropathy indication.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- CuraGen Corp. (CRGN) announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to CR002, a fully human monoclonal antibody, as a potential treatment to slow the...

U.S. HHS buys new anthrax vaccine for stockpile.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- U.S. Department of Health and Human Services (HHS) Secretary Tommy G. Thompson announced that HHS has awarded a contract for $877.5 million to VaxGen, Inc., to manufacture and deliver 75 million doses...

Cocaine pharmacology and pharmacotherapies for its abuse reviewed.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers review cocaine pharmacology and current pharmacotherapies for its abuse in a recent issue of Bioorganic and Medicinal Chemistry. "Cocaine abuse continues to be prevalent and effective...

Long-term use of depo-provera contraceptive injection may cause osteoporosis.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) announced on November 17, 2004, that a "black box" warning will be added to the labeling of Depo-Provera Contraceptive Injection, indicating that prolonged...

New platform design launched for company's aesthetic systems.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Cutera, Inc., (CUTR), a manufacturer of laser and other light-based aesthetic systems, has introduced a new platform design for aesthetic systems. The first application available in this tabletop...

Study patients clear African sleeping sickness parasite in DB289 phase IIb trial.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Immtech International, Inc., (IMM) announced that all 30 patients participating in the concluded phase IIb extended dose regimen arm of its clinical trial of DB289 for treating African sleeping sickness...

Clinical trial study for PreHistin to begin.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Cobalis Corp. (CLSC), a pharmaceutical company specializing in the development of antiallergy medications, announced the start of a 6-week clinical trial study with 624 patients, as a part of the...

Pharma companies collaborate on Alzheimer and Parkinson disease candidates.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- NeuroSearch (NEUR.CO) is collaborating with Boehringer Ingelheim (BI) to develop the drug candidate NS2330 for the treatment of Alzheimer and Parkinson diseases. As an important part of the...

Taking statin slowed progression of Alzheimer disease, new study shows.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A new study has found evidence that taking a commonly prescribed cholesterol-lowering statin drug slowed cognitive decline and improved depressive symptoms in patients with mild to moderate Alzheimer...

Study: FG-2216 increases endogenous EPO production in humans.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- FibroGen, Inc., announced that oral administration of FG-2216, the company's investigational therapy for anemia, was safe and well-tolerated and significantly increased production of endogenous...

Earlier cardiac catheterization reduces risk of mortality in high-risk patients.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Earlier and more aggressive treatment for patients at high risk of heart attack can reduce their chances of dying during hospitalization, but such treatment often is underutilized, new Cleveland...

Preclinical data of Antrin to treat vulnerable plaque presented at AHA.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Pharmacyclics, Inc., (NASDAQ:PCYC) announced preclinical findings demonstrating that Antrin (motexafin lutetium) angiophototherapy leads to regression and stabilization of vulnerable plaques in various...

Company completes first phase of ThraxVax design.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Circle Group Holdings, Inc., (CXN) has completed the phase I design of its homeland security technology, ThraxVac, and produced a prototype model and promotional DVD for interested buyers. The DVD...

New technology promises to cut time in discovery of antibody drugs.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Affitech AS, the human antibody discovery and development company, launched a technology at BioEurope 2004 that promises to dramatically cut the time needed to discover new antibody drugs and their...

Collaboration for aspirin-resistance testing announced.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Corgenix Medical Corp. (CONX) and AspirinWorks, a division of Creative Clinical Concepts, Inc., (CCC), both headquartered in Denver, Colorado, announced that together they have entered into a license...

QVAR in patented Easi-Breathe inhaler launches in United Kingdom.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- IVAX Corporation (IVX) announced the launch of its asthma medicine QVAR in its patented Easi-Breathe inhaler in the United Kingdom. IVAX has been selling QVAR in the United Kingdom, Ireland, France,...

Vaginal dryness can be treated for menopausal women who suffer from condition.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- According to a new Harris Interactive survey, approximately 71% of women over 45 attribute the pain or discomfort they experience during sex to a menopausal symptom called atrophic vaginitis. The...

IRH data presented at International Congress on Autoimmune Diseases.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Hollis-Eden Pharmaceuticals, Inc., (HEPH) presented new data at the Fourth International Congress on Autoimmune Diseases in Budapest, Hungary, on the potential role of immune regulating hormones (IRHs)...

Fluid diagnostics company receives award.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- OraSure Technologies announced that its OraQuick Advance Rapid HIV-1/2 Antibody Test has been awarded a 2004 "Best of What's New" award by Popular Science magazine in the Personal Health category. ...

Generic drug maker named Best Overall Pharmaceutical Products Manufacturer.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Par Pharmaceutical Companies, Inc., (NYSE:PRX), a leading developer, manufacturer and marketer of generic pharmaceuticals, has won the 2004 DIANA Award for Best Overall Pharmaceutical Products...

Technology Council names biotech company early stage company of the year.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- PTC Therapeutics, Inc., (PTC) announced that it has been selected by the New Jersey Technology Council (NJTC) as the 2004 Early Stage company of the Year. The award was presented at the NJTC Awards...

CRO names VP of project management, Joseph Parks.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Clinimetrics Research Associates, Inc., has named Joseph Parks vice president of project management for global operations. "In leading our project management department, Joseph brings over 17 years...

Pharma companies will look to public institutions for productivity help in 2005.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- According to Life Science Insights (LSI), an IDC company, 2005 will see a continued evolution of the private/public funding model within drug discovery and development. The discovery model for...

Anti-infective technologies company receives NASDAQ noncompliance notification.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- V.I. Technologies, Inc. (VITX), a biotechnology company developing anti-infective technologies, reported that the NASDAQ Stock Market, Inc. had notified the company that it does not comply with the...

Neuro-monitoring system to measure cerebral blood flow to launch.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Integra LifeSciences Holdings Corporation (IART) announced that it plans to market and sell the NeuroSensor Cerebral Blood Flow and Intracranial Pressure System (NeuroSensor), a neuro-monitoring system...

Accelerated partial breast irradiation new option for breast cancer patients.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Women diagnosed with breast cancer must weigh the options between old tried- and-true and next-generation breast cancer treatments An estimated 216,000 American women will be diagnosed with breast...

Breast cancer study examines new radiofrequency ablation assisted lumpectomy.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- The University of Arkansas for Medical Sciences (UAMS), and RITA Medical Systems, Inc., (RITA) announced that the first patient in a planned series of 30 received a radiofrequency ablation-assisted...

Plasma prolactin levels associated with increased postmenopausal disease risk.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Study findings suggest that plasma prolactin levels are associated with increased postmenopausal risk of breast cancer. "Prolactin is important in human breast development, and substantial...

Private practice in Munich, Germany, selects mammography system.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A new private practice in Munich, Germany, has chosen Sectra's revolutionary digital mammography system, Sectra MicroDose Mammography. The new practice will focus on the low-dose concept and will...

Biopharma reports third quarter 2004 results, clinical achievements.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Progenics Pharmaceuticals, Inc., (NASDAQ: PGNX) announced its results of operations for the third quarter ended September 30, 2004, and for the first 9 months of 2004. Revenues for the third...

Biopharmaceutical company reports third quarter financial, operating results.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- IntraBiotics Pharmaceuticals, Inc., (IBPI) reported financial and operating results for the third quarter and 9 months ended September 30, 2004. IntraBiotics reported a net loss applicable to common...

Biopharmaceuticals company announces third quarter results, progress made.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Keryx Biopharmaceuticals announced its financial results for the third quarter ended Sept. 30, 2004. At Sept. 30, 2004, Keryx announced cash, cash equivalents, interest receivable and investment...

Biotech company announces restructured agreement for cancer drug.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Ligand Pharmaceuticals announced that it has restructured its agreement with Eli Lilly and Company with respect to the royalties payable to Lilly on sales of Ligand's marketed cancer drug Ontak...

Biotech company reports loss of $0.03 per share.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) reported financial results for the first fiscal quarter ended September 30, 2004. The company also reported several achievements during the last quarter, both...

Company reports Q3 results, provides MS-325 regulatory update.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- EPIX Pharmaceuticals, Inc., (EPIX), a developer of pharmaceuticals for magnetic resonance imaging (MRI), announced its financial results for the third quarter 2004 and provided an update on the...

Company reports increase in income and revenue; discusses Inveresk merger.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Charles River Laboratories International, Inc., (CRL) reported third-quarter 2004 net sales of $176.0 million, a 16.4% increase over the $151.2 million reported in the third quarter of 2003. Net...

Company reports third quarter results, Chrysalin product activities.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- OrthoLogic Corp. announced results for the third quarter ended Sept. 30, 2004. It also updated its product development activities related to its Chrysalin Product Platform. OrthoLogic reported a...

Dermatology pharmaceutical company announces financing, new hires.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Neosil Incorporated announced that it closed a $32 million placement of series A Preferred Stock to a group of investors led by MPM Capital and Burrill & Company. The financing will enable Neosil...

Developer of surgical and diagnostic products announces financial results.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Neoprobe Corporation (OTCBB:NEOP) announced consolidated operating results for the third quarter of 2004. Third quarter results included revenues of $1.7 million, representing increases of 46%...

Imaging services company reports on acquisition, EMR software development.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Bio-Imaging Technologies, Inc., (BITI) announced its financial results for the third quarter ended September 30, 2004. Mark L. Weinstein, president and CEO of Bio-Imaging, said, "As the third...

Managed care company announces third quarter results up 261%.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- NationsHealth, Inc., (NASDAQ:NHRX) announced financial results for its third quarter ended September 30, 2004. Net revenue for the third quarter of 2004 was $20.1 million, up 261% over the third...

Microcatheter systems developer receives notice from Nasdaq regarding bid price.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Cardima, Inc., (Nasdaq SC: CRDM) reported that it has received written notice from Nasdaq that, in accordance with Nasdaq Marketplace Rule 4310(c)(8)(D), the company was provided an additional 180 days,...

Newborn health company reports third quarter revenue and earnings.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Natus Medical Incorporated (Nasdaq:BABY) reported financial results for the 3 and 9 months ended September 30, 2004. Revenue increased 18%, or $1.3 million, to $9.0 million for the third quarter...

Pharmaceutical company reports fourth quarter loss of $0.28 per share.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Advanced Magnetics, Inc., (AVM) announced operating results and revenues for the fourth fiscal quarter and year ended September 30, 2004. Revenues for the quarter were $883,598 as compared to...

Pharmaceutical firm reports loss of $0.18 per share.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Ariad Pharmaceuticals, Inc., (ARIA) announced consolidated financial results for the quarter ended September 30, 2004, and provided an overview of the clinical development of AP23573. "In the third...

Pharmaceutical sector looks to improve cash management and reduce risk.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Volatility in the pharmaceutical industry, caused by factors ranging from merger activity to recent reports of aggressive accounting issues at high-profile companies, has increased industry credit risk...

ARICEPT maker launches marketing sub in India.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Eisai Co., Ltd., announced that on October 27, 2004, it has established its pharmaceuticals marketing subsidiary, Eisai Pharmaceuticals India Private, Ltd., in India. In India, Eisai...

Biotech establishes new business units for pain and oncology.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Ligand Pharmaceuticals announced that it has established separate therapeutically focused business units for its pain and oncology products. Patrick M. Shea, formerly vice president of marketing,...

Biotechnology company enters strategic marketing agreement with Body Blue.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Helix BioMedix (HXBM.OB) has entered into a strategic marketing agreement with Body Blue, Inc., under which Body Blue will market a wide array of proprietary Helix BioMedix peptides for use in a number...

Company raises over $25M, announces CCP Worldwide merger.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Dyadic International, Inc., (DYAD), a biotechnology company focused on the discovery, development, and manufacturing of proteins and other biological products for industrial and biopharmaceutical...

Defibrillator maker ranked as fourth fastest growing technology company.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Cardiac Science, Inc., (DFIB), a manufacturer of life-saving automatic public access defibrillators (AEDs), announced that it ranked No. 4 on the 2004 Deloitte Technology Fast 500, a ranking of the 500...

Dendrite inks reseller agreement.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- MedManage Systems, Inc., a provider of prescription drug-sampling solutions, and Dendrite International, Inc., (DRTE), a provider of clinical, marketing, and sales solutions for the pharmaceutical...

Digital radiography technology company signs OEM agreement in Spain.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Imaging Dynamics Company Ltd. has completed an Original Equipment Manufacturer (OEM) agreement with Radiologia S.A. The arrangement will see Radiologia use IDC's Xplorer very high density CCD...

Dow invests in new facilities to support Asia growth.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Dow Corning Corp. has embarked on an expansion of its Songjiang (People's Republic of China) Application Center, increasing the company's capability to provide innovative solutions for customers in...

European drug developer awards $1.4M study to ECG services company.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT) (ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, announced that it has been awarded a thorough phase I ECG study...

Marketing contract announced for Secure Balance, wireless gas alarm products.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Ingen Technologies, Inc., has signed a marketing contract with Stanford Trading Center, Inc., to market Secure Balance and patented wireless gas alarm products for Ingen Technologies. Stanford...

New company to develop, produce patient-specific cancer vaccines.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Baylor Health Care System announced its formation of a cancer immunotherapy company, known as ODC Therapy, Inc. ODC will develop, produce and distribute customized cancer vaccines, including a...

Patient recruitment firm reports 33% increase in patient panel.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Acurian, Inc., a full-service provider of site and patient recruitment solutions, announced that its proprietary patient panel now contains more than 8 million people in the U.S. who are actively...

Pharmacy services provider selects regulation solution, acquires pharmacy.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Axentis announced that NeighborCare, Inc., has selected Axentis Enterprise as its Sarbanes-Oxley solution. "Following a comprehensive search, we selected Axentis Enterprise to help manage our first...

Provider of microfluidic analytical systems announces sales partnership.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Nanostream announced its entry into the Japanese life sciences market through a sales distribution partnership with CTC Laboratory Systems Corporation (CTCLS). CTCLS, a provider of technology...

Sigma-Aldrich catalog, safety data available in integrated software database.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Synthematix, Inc., a provider of chemistry reaction planning and electronic laboratory notebook (ELN) systems for scientific knowledge management, announced that Sigma-Aldrich's (SIAL) catalog and...

OC Auto Micro 80 analyzer detects blood in stool samples.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Polymedco, Inc., has announced the addition of a new analyzer to their existing offering of automated testing platforms. The OC Auto Micro 80 analyzer processes a new, FDA-cleared immunochemical test to...

European cancer organization offers guidelines for treating anemia.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- New European Organization for Research and Treatment of Cancer (EORTC) guidelines aim to assist physicians in managing anemia more effectively in their patients with cancer by providing advice on the...

Listeria-based cancer vaccines segregate immunogenicity from toxicity.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Listeria-based cancer vaccines segregate immunogenicity from toxicity. According to a study from the United States, "The facultative intracellular bacterium Listeria monocytogenes is being developed...

Freezor MAX obtains FDA approval in the U.S.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- CryoCath Technologies, Inc., announced that its Freezor MAX catheter device has received premarket application supplement approval from the U.S. Food and Drug Administration (FDA), allowing the company...

Scientists have discovered several novel potent NCX inhibitors.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Synthesis and structure-activity relationships of phenoxypyridine derivatives as novel inhibitors of the sodium-calcium exchanger According to recent research published in the journal Bioorganic &...

Company says implantable defibrillators are cost-effective treatment for heart failure patients.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Medtronic announced that additional scientific data demonstrate that implantable cardioverter-defibrillators (ICDs) are a cost-effective therapy for heart failure patients. In March 2004, results...

Company updates preclinical findings for synthetic vascular graft.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Kensey Nash Corporation presented results from preclinical research on its synthetic vascular graft at the most recent American Heart Association's Scientific Sessions. The company said its findings...

Microvolt T-wave alternans tested in non-ischemic patient population.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Cambridge Heart, Inc., (OTCBB:CAMH) presented positive scientific evidence at the annual American Heart Association meeting that demonstrates the efficacy of Microvolt T-wave alternans (MTWA) testing...

Pharmaceutical company announces results of heart disease risk study.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- LipoScience announced the results of a major study confirming that the number of LDL particles (LDL-P) measured by nuclear magnetic resonance (NMR) spectroscopy provides better prediction of heart...

Pharmaceutical company comments on results of coronary artery disease study.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- King Pharmaceuticals reported that data from the Prevention of Events with Angiotensin-Converting-Enzyme Inhibitors (PEACE) trial released at the recent American Heart Association meeting failed to...

Pharmaceutical company reports on atherosclerosis clinical trail.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals commented on the results of the ARBITER 2 study, which was conducted by Walter Reed Army Medical Center and presented during the 2004 Scientific Sessions of the American Heart...

Research shows generic statin drugs produce same results as brand-name counterparts.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- At the most recent American Heart Association Scientific Sessions, researchers from Kaiser Permanente presented data that showed patients who use a generic statin drug rather than its brand-name...

Selective delipidation process used to help remove cholesterol from cells.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Lipid Sciences announced that researchers have successfully used its "selective delipidation" process to create a modified form of HDL that is known to be more effective in reverse cholesterol...

Simultaneous activation of JNK and p38 by MLK7 may affect cardiac decompensation.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Transgenic mice with cardiac-specific over-expression of MLK7 have increased mortality when exposed to chronic beta-adrenergic stimulation. According to recent research from the United States,...

Study shows benefits of blood pressure treatment.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Results announced at the recent American Heart Association meeting showed that the life-saving benefits of perindopril (Coversyl), the angiotensin-converting enzyme (ACE) inhibitor used in the European...

Study shows differences in cardiovascular risk among cox-2 inhibitors.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Research published in a recent issue of Atherosclerosis showed cox-2 inhibitor Vioxx caused biochemical changes that contribute to the development of heart disease, while Celebrex, another cox-2...

Addition of INTEGRILIN provides superior platelet inhibition with stenting.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Millennium Pharmaceuticals, Inc., (NASDAQ:MLNM) announced that in the Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets (CLEAR Platelets) trial, the addition of INTEGRILIN, a...

Data confirms enzyme's potential as a target for cardiovascular diagnosis.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- High levels of an enzyme - lipoprotein-associated phospholipase A2 (Lp-PLA2) - believed to trigger a cascade of inflammatory events in atherosclerosis can independently predict increased risk of stroke,...

Nanobacterial link to abnormal calcification described in newly released book.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Nanobac Life Sciences, Inc., (OTCPK:NNBP) announced the release of The Calcium Bomb, a book that gives general audiences a view of the nanobacterial link to abnormal calcification affecting millions of...

Study analyzes weather patterns and hospitalizations.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report described weather changes associated with hospitalizations for cardiovascular diseases and stroke in California, 1983-1998. According to published research from the United States,...